Good morning. I am Clay Siegall, President, Chief Executive Officer, and Chairman of Immunome, Inc. Welcome to Immunome's 2026 Annual Meeting of Stockholders. I now call the meeting to order. It is 9:00 A.M. Pacific Time, and the polls are open for voting. As a reminder, if you have provided your proxy card or otherwise voted in advance of the meeting, your shares will be voted accordingly. There is no need to vote during this meeting unless you want to change your vote. If you registered to attend this meeting and have not already voted, please vote your shares online. Attending today are members of our board of directors and executive leadership team, and representatives of Ernst & Young LLP, the company's independent registered public accounting firm.
Jim Raitt with American Election Services, LLC, has been appointed as the Inspector of Elections for today's meeting, and Mr. Raitt has previously taken his oath as Inspector of Elections. If you wish to ask a question during this meeting, please submit it on our virtual stockholder meeting website. We will address only questions that are appropriate and relevant to this meeting. Questions unrelated to the proposals may be directed to Investor Relations through our website. We will now proceed with the business of the meeting. The record date for this meeting is April 16th, 2026, and stockholders of record on that date are entitled to vote at this meeting. I have an affidavit from Broadridge Financial Solutions, Inc., certifying that on April 24th, 2026, they commenced the mailing of the notice of annual meeting of stockholders of Immunome.
The notice was deposited in the United States Mail to each of the stockholders of record at the close of business on April 16th, 2026. A certified list of the stockholders of the company as of the close of business on the record date has been provided to the company by Equiniti Trust Company, LLC, the company's transfer agent. That list shows that on the record date, there were 113,249,519 shares of common stock issued and outstanding. On each proposal, stockholders are entitled to one vote for each share of common stock registered in their name. I have been advised that a majority of the issued and outstanding shares entitled to vote are present, constituting a quorum. There are four proposals to be considered by the stockholders.
The first proposal is the election of three nominees as Class III directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified. The candidates are James Boylan, Philip Wagenheim, and Sandra Swain. The second proposal is the ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31st, 2026. The third proposal is the advisory vote on the compensation of the company's named executive officers as described in the proxy statement. The fourth proposal is an advisory vote on the frequency of advisory votes on executive compensation. There is no further business to come before the meeting. I will ask Sandra Stoneman, our Chief Legal Officer, whether there are any stockholder questions to be addressed.
Thank you, Dr. Siegall. Our records show that no questions have been submitted.
Based on the preliminary report of the Inspector of Elections, the proposal to elect Mr. Boylan, Mr. Wagenheim, and Dr. Swain as Class III directors to serve until the 2029 annual meeting is carried. The selection of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026, is ratified. The advisory vote on the compensation of the company's named executive officers is approved, and the advisory vote on the frequency of executive compensation votes that received the greatest number of votes was one year. We will report voting results in a Form 8-K to be filed with the SEC within four business days of this meeting.
If only preliminary voting results are available at that time, we expect to report our final voting results in an amendment to the Form 8-K within four business days after the final results are known to us. As there is no further business, this meeting is adjourned. Thank you for your attendance.
That concludes our meeting today. You may now disconnect.